CorMedix Inc. <CRMD.O>: Oppenheimer initiates coverage with outperform rating; price target $15
CRMD•Related News
Versus Systems names Brian Goldenberg CFO
VS•
Levi Strauss to webcast third-quarter earnings conference call
LEVI•
Guardforce AI FY26 H1 net loss widens to USD 3.12 million; revenue rises 6.4% to USD 18.27 million
GFAI•
Core AI Holdings flags Nasdaq notice on minimum shareholders’ equity shortfall
CHAI•
Canada FX Debt - Canadian dollar weakens, benchmark yield climbs
FXC•